HSHHSH Health Technology Supplier Hub
Home › Suppliers › Clinisys › Risk

Clinisys: risk summary

Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.

Financial

Latest full-year results from official filings.

Recent change of ownership; current owner not yet confirmed from official filings.

Financial health not assessed until ownership and accounts are verified.

Researched 8 Nov 2026

Adverse media

Credible news about incidents, disputes, legal action or restructuring in the last 24 months.

No adverse media involving Clinisys found in HSH's search of the last 24 months. Jul 2025: Clinisys acquired US lab software company Orchard Software from Francisco Partners; terms were not disclosed.

Researched 10 Nov 2026

Cyber & information governance

Data breaches, cyber incidents, regulator action and assurance status.

No data breaches, ransomware incidents or regulator action involving Clinisys found in HSH's search of the last 24 months. NHS DSPT status not yet checked.

Researched 10 Nov 2026

Regulatory & clinical safety

Recalls, safety notices, regulator action and clinical safety concerns.

Apr 2025: Health Canada listed a Type II recall of a Clinisys SQ Blood Bank instrument driver, after partial data from a timed-out sample could merge with the next sample's data; customers were told to contact the manufacturer.

Researched 10 Nov 2026

Contract performance

Contract delivery, go-lives, terminations and disputes.

Sep 2025: Aneurin Bevan University Health Board's blood transfusion service went live on Clinisys WinPath, replacing an end-of-life LIMS, with staff reporting a smooth switch. No terminations or disputes involving Clinisys found in HSH's search of the last 24 months.

Researched 10 Nov 2026